Detail page

Knowledge Web

Person

Christopher I. Li

Arzt

Name	Christopher I. Li
Place	Seattle, Wash. (Wirkungsort) USA
Academic degree	PhD, MD, BSc
Profession	Arzt (characteristic profession) Facharzt für Epidemiologie
Variant	Christopher Ifu Li
Related	Fred Hutchinson Cancer Research Center (Seattle, Wash.) (Division of Public Health Sciences) University of Washington (Department of Epidemiology)
Source	Homepage; Directory of Physicians in the US
Record type	Person
GND-Identifier	140396985
Record ID	140396985
Involved in show all Functional quality of life among newly diagnosed young adult colorectal cancer survivors compared to older adults: results from the ColoCare Study Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study Lessons to inform interventions to reduce racial and ethnic health disparities within hematologic malignancies ASO Visual Abstract: Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen Receptor-Positive Breast Cancer Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer Alcohol consumption, smoking, and invasive breast cancer risk after ductal carcinoma in situ Association between antidepressant use and second breast cancer event after ductal carcinoma in situ diagnosis: a nested case–control study Cohort profile: Biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer recurrence and survival – the FOCUS Consortium Racial/ethnic disparities in risk of breast cancer mortality by molecular subtype and stage at diagnosis Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast Cancer Reproductive and menopausal factors and risk of second primary breast cancer after in situ breast carcinoma Alcohol Intake and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status Among Women Aged 55 to 74 Years Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer Breast Cancer Epidemiology Interactions between Body Mass Index and Hormone Therapy and Postmenopausal Breast Cancer Risk (United States) The Relationship Between Various Measures of Cigarette Smoking and Risk of Breast Cancer Among Older Women 65–79 years of Age (United States)

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Christopher I. Li

Functional quality of life among newly diagnosed young adult colorectal cancer survivors compared to older adults: results from the ColoCare Study

Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study

Lessons to inform interventions to reduce racial and ethnic health disparities within hematologic malignancies

ASO Visual Abstract: Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen Receptor-Positive Breast Cancer

Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer

Alcohol consumption, smoking, and invasive breast cancer risk after ductal carcinoma in situ

Association between antidepressant use and second breast cancer event after ductal carcinoma in situ diagnosis: a nested case–control study

Cohort profile: Biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer recurrence and survival – the FOCUS Consortium

Racial/ethnic disparities in risk of breast cancer mortality by molecular subtype and stage at diagnosis

Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer

Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast Cancer

Reproductive and menopausal factors and risk of second primary breast cancer after in situ breast carcinoma

Alcohol Intake and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status Among Women Aged 55 to 74 Years

Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer

Breast Cancer Epidemiology

Interactions between Body Mass Index and Hormone Therapy and Postmenopausal Breast Cancer Risk (United States)

The Relationship Between Various Measures of Cigarette Smoking and Risk of Breast Cancer Among Older Women 65–79 years of Age (United States)